Eculizumab Gains FDA Approval Drug Discovery & Development The US Food and Drug Administration (FDA) granted accelerated approval for eculizumab (Soliris, Alexion Inc.) for the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab is a monoclonal antibody that ... Eculizumab receives accelerated approval for pediatric, adult hemolytic uremic ... FDA Approves Soliris for Rare Pediatric Blood Disorder FDA Approves Alexion's Soliris For Treatment Of AHUS - Update |
Sunday, September 25, 2011
Eculizumab Gains FDA Approval - Drug Discovery & Development
Viking Refrigerators
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment